Table 2.
Model | Cohort | AUC (95% CI) | Accuracy | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|---|---|
Clinical model | Training | 0.762 (0.667–0.846) | 0.748 | 0.721 | 0.780 | 0.800 | 0.696 |
Testing | 0.799 (0.672–0.917) | 0.782 | 0.750 | 0.815 | 0.808 | 0.759 | |
Radiomics features-combined model | Training | 0.879 (0.805–0.939) | 0.811 | 0.770 | 0.86 | 0.870 | 0.754 |
Testing | 0.724 (0.575–0.855) | 0.673 | 0.536 | 0.815 | 0.750 | 0.629 | |
Clinical–radiomics model | Training | 0.886 (0.819–0.940) | 0.820 | 0.803 | 0.840 | 0.860 | 0.778 |
Testing | 0.836 (0.707–0.937) | 0.782 | 0.750 | 0.815 | 0.808 | 0.759 |
In the process of establishing scout models to select features, only the cross-validation performance was assessed to avoid information leakage. The bold values is optimal value.
AUC, area under the curve; PPV, positive predictive value; NPV, negative predictive value.